177 related articles for article (PubMed ID: 16649834)
1. The effects of long-term clozapine add-on therapy on the rehospitalization rate and the mood polarity patterns in bipolar disorders.
Chang JS; Ha KS; Young Lee K; Sik Kim Y; Min Ahn Y
J Clin Psychiatry; 2006 Mar; 67(3):461-7. PubMed ID: 16649834
[TBL] [Abstract][Full Text] [Related]
2. Is clozapine a mood stabilizer?
Zarate CA; Tohen M; Banov MD; Weiss MK; Cole JO
J Clin Psychiatry; 1995 Mar; 56(3):108-12. PubMed ID: 7883728
[TBL] [Abstract][Full Text] [Related]
3. Clozapine use reduced psychiatric hospitalization and emergency room visits in patients with bipolar disorder independent of improved treatment regularity in a three-year follow-up period.
Wu CS; Wang SC; Liu SK
Bipolar Disord; 2015 Jun; 17(4):415-23. PubMed ID: 25295837
[TBL] [Abstract][Full Text] [Related]
4. Reduction in hospital stay of chronic schizophrenic patients after long-term clozapine treatment.
Ahn YM; Chang JS; Kim Y; Lee KY; Kim JH; Kim SC; Maeng SJ; Kim YS
Int Clin Psychopharmacol; 2005 May; 20(3):157-61. PubMed ID: 15812266
[TBL] [Abstract][Full Text] [Related]
5. Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series.
Hummel B; Dittmann S; Forsthoff A; Matzner N; Amann B; Grunze H
Neuropsychobiology; 2002; 45 Suppl 1():37-42. PubMed ID: 11893876
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
Suppes T; Webb A; Paul B; Carmody T; Kraemer H; Rush AJ
Am J Psychiatry; 1999 Aug; 156(8):1164-9. PubMed ID: 10450255
[TBL] [Abstract][Full Text] [Related]
7. Effects of clozapine on sleep in bipolar and schizoaffective disorders.
Armitage R; Cole D; Suppes T; Ozcan ME
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1065-70. PubMed ID: 15610918
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic adjunctive therapy to mood stabilizers and 1-year rehospitalization rates in bipolar disorder: A cohort study.
Hochman E; Krivoy A; Schaffer A; Weizman A; Valevski A
Bipolar Disord; 2016 Dec; 18(8):684-691. PubMed ID: 27933713
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
Narendran R; Young CM; Valenti AM; Pristach CA; Pato MT; Grace JJ
J Clin Psychiatry; 2001 Jul; 62(7):509-16. PubMed ID: 11488360
[TBL] [Abstract][Full Text] [Related]
10. The Role of Clozapine as a Mood Regulator in the Treatment of Rapid Cycling Bipolar Affective Disorder.
Kılınçel O; Kılınçel Ş; Gündüz C; Cangür Ş; Akkaya C
Turk Psikiyatri Derg; 2019; 30(4):268-271. PubMed ID: 32594488
[TBL] [Abstract][Full Text] [Related]
11. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.
Banov MD; Zarate CA; Tohen M; Scialabba D; Wines JD; Kolbrener M; Kim JW; Cole JO
J Clin Psychiatry; 1994 Jul; 55(7):295-300. PubMed ID: 8071290
[TBL] [Abstract][Full Text] [Related]
12. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
[TBL] [Abstract][Full Text] [Related]
13. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ
Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520
[TBL] [Abstract][Full Text] [Related]
14. Clozapine in the management of bipolar and schizoaffective manic episodes resistant to standard treatment.
Mahmood T; Devlin M; Silverstone T
Aust N Z J Psychiatry; 1997 Jun; 31(3):424-6. PubMed ID: 9226089
[TBL] [Abstract][Full Text] [Related]
15. Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.
Tohen M; Wang WV; Leboyer M; Jen KY
J Clin Psychiatry; 2012 Jul; 73(7):e913-7. PubMed ID: 22901362
[TBL] [Abstract][Full Text] [Related]
16. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
[TBL] [Abstract][Full Text] [Related]
17. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
Guille C; Sachs GS; Ghaemi SN
J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
[TBL] [Abstract][Full Text] [Related]
18. Low doses of clozapine may stabilize treatment-resistant bipolar patients.
Fehr BS; Ozcan ME; Suppes T
Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):10-4. PubMed ID: 15538596
[TBL] [Abstract][Full Text] [Related]
19. Clozapine treatment in an adolescent with bipolar disorder.
Masi G; Milone A
Panminerva Med; 1998 Sep; 40(3):254-7. PubMed ID: 9785928
[TBL] [Abstract][Full Text] [Related]
20. Clozapine for treatment-refractory mania.
Calabrese JR; Kimmel SE; Woyshville MJ; Rapport DJ; Faust CJ; Thompson PA; Meltzer HY
Am J Psychiatry; 1996 Jun; 153(6):759-64. PubMed ID: 8633686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
